Document:

exv10w11

 

Exhibit 10.11

INDEMNIFICATION AGREEMENT

     This Indemnification Agreement (the “Agreement”) made and entered into this October 15, 2004
(the “Effective Date”), by and between 3am Labs, Inc., a Delaware corporation (the “Company”), and
Michael Simon (the “Indemnitee”).

     WHEREAS, it is essential that the Company be able to retain and attract as directors the most
capable persons available;

     WHEREAS, the Company’s Bylaws permit it to enter into indemnification arrangements and
agreements;

     WHEREAS, the Company desires to provide the Indemnitee with specific contractual assurances of
the Indemnitee’s rights to full indemnification against litigation risks and expenses (regardless,
among other things, of any amendment to or revocation of the Company’s Bylaws or any change in the
ownership of the Company or the composition of its Board of Directors) and, to the extent insurance
is available, the coverage of the Indemnitee under the Company’s directors and officers liability
insurance policies; and

     WHEREAS, the Indemnitee is relying upon the rights afforded under this Agreement in accepting
Indemnitee’s position as a director of the Company.

     NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, the
Company and Indemnitee do hereby covenant and agree as follows:

     1. Definitions.

          (a) “Corporate Status” describes the status of a person who is serving or has served (i) as a
director, officer or employee of the Company, (ii) in any capacity with respect to any employee
benefit plan of the Company, or (iii) as a director, partner, member, trustee, officer, employee,
or agent of any other Entity at the written request of the Company.

          (b) “Entity” shall mean any corporation, partnership, limited liability company, joint
venture, trust, foundation, association, organization or other legal entity and any group or
division of the Company or any of its subsidiaries.

          (c) “Expenses” shall mean all reasonable fees, costs and expenses incurred in connection with
any Proceeding (as defined below), including, without limitation, attorneys’ fees, disbursements
and retainers (including, without limitation, any such fees, disbursements and retainers incurred
by Indemnitee pursuant to Section 10 of this Agreement), fees and disbursements of expert
witnesses, private investigators and professional advisors (including, without limitation,
accountants), court costs, transcript costs, fees of experts, travel expenses, duplicating,
printing and binding costs, telephone and fax transmission charges, postage, delivery services,
secretarial services, and other disbursements and expenses.

          (d) “Indemnifiable Expenses,” “Indemnifiable Liabilities” and “Indemnifiable Amounts” shall
have the meanings ascribed to those terms in Section 3(a) below.

1

 

          (e) “Liabilities” shall mean judgments, damages, liabilities, losses, penalties, excise taxes,
fines and amounts paid in settlement.

          (f) “Proceeding” shall mean any threatened, pending or completed claim, action, suit,
arbitration, alternate dispute resolution process, investigation, administrative hearing, appeal,
or any other proceeding, whether civil, criminal, administrative or investigative, whether formal
or informal, including a proceeding initiated by Indemnitee pursuant to Section 10 of this
Agreement to enforce Indemnitee’s rights hereunder.

     2. Services of Indemnitee. It is the intent of this Agreement to secure for
Indemnitee rights of indemnity that are as favorable as may be permitted under the law and public
policy of the State of Delaware. In consideration of the Company’s covenants and commitments
hereunder, Indemnitee agrees to serve as a director of the Company; provided, that
this Agreement shall not impose any obligation on Indemnitee or the Company to continue
Indemnitee’s service to the Company beyond any period otherwise required by law or by other
agreements or commitments of the parties, if any.

     3. Agreement to Indemnify.

     The Company agrees to indemnify Indemnitee as follows:

          (a) Subject to the exceptions contained in Section 4(a) below, if Indemnitee becomes a party
or is threatened to be made a party to any Proceeding (other than an action by or in the right of
the Company) from and after the Effective Date by reason of Indemnitee’s Corporate Status,
Indemnitee shall be indemnified by the Company against all Expenses and Liabilities incurred or
paid by Indemnitee in connection with such Proceeding (referred to herein as “Indemnifiable
Expenses” and “Indemnifiable Liabilities,” respectively, and collectively as “Indemnifiable
Amounts”).

          (b) Subject to the exceptions contained in Section 4(b) below, if Indemnitee becomes a party
or is threatened to be made a party to any Proceeding from and after the Effective Date by or in
the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate
Status, Indemnitee shall be indemnified by the Company against all Indemnifiable Expenses.

     4. Exceptions to Indemnification. Indemnitee shall be entitled to indemnification
under Sections 3(a) and 3(b) above in all circumstances other than the following:

          (a) If indemnification is requested under Section 3(a) and it has been adjudicated by a court
of competent jurisdiction that, in connection with the subject of the Proceeding out of which the
claim for indemnification has arisen, (a) Indemnitee failed to act in good faith and in a manner
Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, (b)
due to Indemnitee’s own gross negligence or willful misconduct, or (c) with respect to any criminal
action or proceeding, Indemnitee had reasonable cause to believe that Indemnitee’s conduct was
unlawful, Indemnitee shall not be entitled to payment of Indemnifiable Amounts hereunder.

          (b) If indemnification is requested under Section 3(b) and

2

 

               (i) it has been adjudicated finally by a court of competent jurisdiction that, in connection
with the subject of the Proceeding out of which the claim for indemnification has arisen,
Indemnitee failed to act in good faith and in a manner Indemnitee reasonably believed to be in or
not opposed to the best interests of the Company, Indemnitee shall not be entitled to payment of
Indemnifiable Expenses hereunder; or

               (ii) it has been adjudicated finally by a court of competent jurisdiction that Indemnitee is
liable to the Company with respect to any claim, issue or matter involved in the Proceeding out of
which the claim for indemnification has arisen, including, without limitation, a claim that
Indemnitee received an improper personal benefit or improperly took advantage of a corporate
opportunity, Indemnitee shall not be entitled to payment of Indemnifiable Expenses hereunder with
respect to such claim, issue or matter unless the Court of Chancery of the State of Delaware shall
determine upon application that, despite the adjudication of liability, but in view of all the
circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnity for such
Indemnifiable Expenses which such court shall deem proper.

     5. Procedure for Payment of Indemnifiable Amounts. Indemnitee shall submit to the
Company a written request specifying the Indemnifiable Amounts for which Indemnitee seeks payment
under Section 3 of this Agreement and the basis for the claim. Subject to Section 4 and applicable
procedural and approval provisions of the General Corporation Law of the State of Delaware, as
amended and in effect from time to time, the Company shall pay such Indemnifiable Amounts to
Indemnitee within twenty (20) calendar days of receipt of the request. At the request of the
Company, Indemnitee shall furnish such documentation and information as are reasonably available to
Indemnitee and necessary to establish that Indemnitee is entitled to indemnification hereunder and
consistent with the requirements of the General Corporation Law of the State of Delaware, as
amended and in effect from time to time.

     6. Indemnification for Expenses of a Party Who is Wholly or Partly Successful.
Notwithstanding any other provision of this Agreement, and without limiting any such provision, to
the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a party to and is
successful, on the merits or otherwise, in any Proceeding, Indemnitee shall be indemnified against
all Expenses reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith.
If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or
otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the
Company shall indemnify Indemnitee against all Expenses reasonably incurred by Indemnitee or on
Indemnitee’s behalf in connection with each successfully resolved claim, issue or matter. For
purposes of this Agreement, the termination of any claim, issue or matter in such a Proceeding by
dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim,
issue or matter.

     7. Effect of Certain Resolutions. Neither the settlement nor termination of any
Proceeding nor the failure of the Company to award indemnification or to determine that
indemnification is payable shall create an adverse presumption that Indemnitee is not entitled to
indemnification hereunder. In addition, the termination of any proceeding by judgment, order,
settlement, conviction, or upon a plea of nolo contendere or its equivalent shall not create a
presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably
believed to be in or not opposed to the best interests of the Company or, with respect

3

 

to any criminal action or proceeding, had reasonable cause to believe that Indemnitee’s action
was unlawful.

     8. Agreement to Advance Interim Expenses. The Company shall pay to Indemnitee all
Indemnifiable Expenses incurred by Indemnitee in connection with any Proceeding, including a
Proceeding by or in the right of the Company, in advance of the final disposition of such
Proceeding, if Indemnitee furnishes the Company with a written undertaking to repay the amount of
such Indemnifiable Expenses advanced to Indemnitee if it is determined by a court of competent
jurisdiction that Indemnitee is not entitled under this Agreement to indemnification with respect
to such Indemnifiable Expenses, which undertaking shall be an unsecured general obligation of the
Indemnitee. The terms and conditions of such undertaking shall be determined by a quorum of the
disinterested members of the Board of Directors, if any, acting in good faith and as required by
the proper exercise of their fiduciary duties or, if not available, then by the written opinion of
independent legal counsel or by the Company’s stockholders.

     9. Procedure for Payment of Interim Expenses. Indemnitee shall submit to the Company
a written request specifying the Indemnifiable Expenses for which Indemnitee seeks an advancement
under Section 8 of this Agreement, together with documentation evidencing that Indemnitee has
incurred such Indemnifiable Expenses. Payment of Indemnifiable Expenses under Section 8 shall be
made no later than twenty (20) calendar days after the Company’s receipt of such request and the
undertaking required by Section 8.

     10. Remedies of Indemnitee.

          (a) Right to Petition Court. In the event that Indemnitee makes a request for payment
of Indemnifiable Amounts under Sections 3 and 5 above or a request for an advancement of
Indemnifiable Expenses under Sections 8 and 9 above and the Company fails to make such payment or
advancement in a timely manner pursuant to the terms of this Agreement, Indemnitee may petition the
appropriate judicial authority to enforce the Company’s obligations under this Agreement.

          (b) Burden of Proof. In any judicial proceeding brought under Section 10(a) above,
the Company shall have the burden of proving that Indemnitee is not entitled to payment of
Indemnifiable Amounts hereunder.

          (c) Expenses. The Company agrees to reimburse Indemnitee in full for any Expenses
incurred by Indemnitee in connection with investigating, preparing for, litigating, defending or
settling any action brought by Indemnitee under Section 10(a) above, or in connection with any
claim or counterclaim brought by the Company in connection therewith, unless the appropriate
judicial authority determines that the Company had no obligations under this Agreement with respect
to the Indemnitee’s request for payment of Indemnifiable Amounts under Sections 3 and 5 above or
request for an advancement of Indemnifiable Expenses under Sections 8 and 9 above.

          (d) Validity of Agreement. Subject to applicable law, including, but not limited to
the General Corporation Law of the State of Delaware, precluding the Company’s compliance with any
provision of this Agreement, the Company shall be precluded from

4

 

asserting in any Proceeding, including, without limitation, an action under Section 10(a)
above, that the provisions of this Agreement are not valid, binding and enforceable or that there
is insufficient consideration for this Agreement and shall stipulate in court that the Company is
bound by all the provisions of this Agreement.

          (e) Failure to Act Not a Defense. The failure of the Company (including its Board of
Directors or any committee thereof, independent legal counsel, or stockholders) to make a
determination concerning the permissibility of the payment of Indemnifiable Amounts or the
advancement of Indemnifiable Expenses under this Agreement shall not be a defense in any action
brought under Section 10(a) above, and shall not create a presumption that such payment or
advancement is not permissible.

     11. Representations and Warranties of the Company. The Company hereby represents and
warrants to Indemnitee as follows:

          (a) Authority. The Company has all necessary corporate power and authority to enter
into, and be bound by the terms of, this Agreement, and the execution, delivery and performance of
the undertakings contemplated by this Agreement have been duly authorized by the Company.

          (b) Enforceability. This Agreement, when executed and delivered by the Company in
accordance with the provisions hereof, shall be a legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, except as such
enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or
similar laws affecting the enforcement of creditors’ rights generally or general equitable
principles, and to the extent limited by applicable federal or state securities laws.

     12. Insurance. To the extent that the Company’s Board of Directors determines it to
be necessary and appropriate, the Company will use commercially reasonable efforts to obtain,
within sixty (60) days of such determination, and maintain a policy or policies of insurance in an
amount not less than $1,000,000 in the aggregate for the Company’s Board of Directors and executive
officers, with reputable insurance companies providing the members of the Board of Directors with
coverage for losses from wrongful acts, and to ensure the Company’s performance of its
indemnification obligations under this Agreement. In all policies of director and officer
liability insurance, Indemnitee shall be named as an insured in such a manner as to provide
Indemnitee at least the same rights and benefits as are accorded to the most favorably insured of
the Company’s officers and directors. Notwithstanding the foregoing, if the Company, after
employing commercially reasonable efforts as provided in this Section, determines in good faith
that such insurance is not reasonably available, if the premium costs for such insurance are
disproportionate to the amount of coverage provided, or if the coverage provided by such insurance
is limited by exclusions so as to provide an insufficient benefit, the Company shall use its
commercially reasonable efforts to obtain and maintain a policy or policies of insurance with
coverage having features as similar as practicable to those described above.

     13. Fees and Expense. During the term of the Indemnitee’s service as a director, the
Company shall promptly reimburse the Indemnitee for all reasonable and documented expenses

5

 

incurred by him in connection with his service as a director or member of any board committee
or otherwise in connection with the Company’s business, provided, that all expenses in excess of
$1,000 (other than travel and lodging expenses incurred in connection with attendance of any
meetings of the board of directors and/or any board committee) shall be approved in writing in
advance by the Company.

     14. Contract Rights Not Exclusive. The rights to payment of Indemnifiable Amounts and
advancement of Indemnifiable Expenses provided by this Agreement shall be in addition to, but not
exclusive of, any other rights which Indemnitee may have at any time under applicable law, the
Company’s Bylaws, as amended, the Company’s Second Amended and Restated Certificate of
Incorporation, or any other agreement, vote of stockholders or directors, or otherwise, both as to
action in Indemnitee’s official capacity and as to action in any other capacity as a result of
Indemnitees’s serving as a director of the Company.

     15. Successors. This Agreement shall be (a) binding upon all successors and assigns
of the Company (including any transferee of all or a substantial portion of the business, stock
and/or assets of the Company and any direct or indirect successor by merger or consolidation or
otherwise by operation of law) and (b) binding on and shall inure to the benefit of the heirs,
personal representatives, executors and administrators of Indemnitee. This Agreement shall
continue for the benefit of Indemnitee and such heirs, personal representatives, executors and
administrators after Indemnitee has ceased to have Corporate Status.

     16. Subrogation. In the event of any payment of Indemnifiable Amounts under this
Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of
contribution or recovery of Indemnitee against other persons, and Indemnitee shall take, at the
request of the Company, all reasonable action necessary to secure such rights, including the
execution of such documents as are necessary to enable the Company to bring suit to enforce such
rights.

     17. Change in Law. To the extent that a change in applicable law (whether by statute
or judicial decision) shall permit broader indemnification than is provided under the terms of the
Second Amended and Restated Certificate of Incorporation or Bylaws of the Company, as amended, and
this Agreement, Indemnitee shall be entitled to such broader indemnification and this Agreement
shall be deemed to be amended to such extent.

     18. Severability. Whenever possible, each provision of this Agreement shall be
interpreted in such a manner as to be effective and valid under applicable law, but if any
provision of this Agreement, or any clause thereof, shall be determined by a court of competent
jurisdiction to be illegal, invalid or unenforceable, in whole or in part, such provision or clause
shall be limited or modified in its application to the minimum extent necessary to make such
provision or clause valid, legal and enforceable, and the remaining provisions and clauses of this
Agreement shall remain fully enforceable and binding on the parties.

     19. Indemnitee as Plaintiff. Except as provided in Section 10 of this Agreement and
in the next sentence, Indemnitee shall not be entitled to payment of Indemnifiable Amounts or
advancement of Indemnifiable Expenses with respect to any Proceeding brought by Indemnitee against
the Company, any Entity which it controls, any director or officer thereof, or any third

6

 

party, unless the Company has consented to the initiation of such Proceeding. This Section
shall not apply to affirmative defenses asserted by Indemnitee in an action brought against
Indemnitee. In connection with any Proceeding in which the Company made payment of Indemnifiable
Amounts or advancement of Indemnifiable Expenses with respect to such Proceeding, any amounts
recovered by the Indemnitee in such Proceeding shall be held in trust for the benefit of the
Company and paid over to the Company as soon as reasonably practical.

     20. Modifications and Waiver. Except as provided in Section 17 above with respect to
changes in applicable law which broaden the right of Indemnitee to be indemnified by the Company,
no supplement, modification or amendment of this Agreement shall be binding unless executed in
writing by each of the parties hereto. No waiver of any of the provisions of this Agreement shall
be deemed or shall constitute a waiver of any other provisions of this Agreement (whether or not
similar), nor shall such waiver constitute a continuing waiver.

     21. General Notices. All notices, requests, demands and other communications
hereunder shall be in writing and shall be deemed to have been duly given (a) when delivered by
hand, (b) when transmitted by facsimile and receipt is acknowledged, or (c) if mailed by certified
or registered mail with postage prepaid, on the third business day after the date on which it is so
mailed:

	 	 	 	 	 	 	 	 	 
	 

	 	(i)
	 	If to Indemnitee, to:
	 	Michael Simon
	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	with copy to:	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	(ii)
	 	If to the Company, to:
	 	3am Labs, Inc	 	 
	 

	 	 	 	 	 	500 Unicorn Park Drive

Woburn, MA 01801

Attn: President	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	with copy to:	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Bingham McCutchen LLP

150 Federal Street

Boston, Massachusetts 02110

Attention: Victor J. Paci, Esq.

Telecopier No.: (617) 951-8736	 	 

7

 

or to such other address as may have been furnished in the same manner by any party to the others.

     22. Governing Law. This Agreement shall be governed by and construed in accordance
with the General Corporation Law of the State of Delaware as to matters within the scope thereof,
and as to all other matters shall be governed by and construed in accordance with the internal laws
of the Commonwealth of Massachusetts, without regard to its principles of conflicts of laws. If
the Agreement is translated into another language, the English language version shall control if
any dispute shall arise over the interpretation of the wording of the Agreement. Each of the
parties to this Agreement hereby agrees that the state and federal courts of the Commonwealth of
Massachusetts shall have exclusive jurisdiction to hear and determine any claims or disputes
between the parties hereto pertaining directly or indirectly to this Agreement, and all documents,
instruments and agreements executed pursuant hereto or thereto, or to any matter arising here from
(unless otherwise expressly provided for herein or therein). To the extent permitted by law, each
party hereby expressly submits and consents in advance to such jurisdiction in any action or
proceeding commenced by any of the other parties hereto in any of such courts, and agrees that
service of such summons and complaint or other process or papers may be made by registered or
certified mail addressed to such party at the address to which notices are to be sent pursuant to
this Agreement. Each of the parties waives any claim that Boston, Massachusetts is an inconvenient
forum or an improper forum based on lack of venue. The choice of forum set forth in this Section
shall not be deemed to preclude the enforcement of any judgment obtained in such forum or the
taking of any action to enforce the same in any other appropriate jurisdiction. Each party hereto
hereby waives, to the fullest extent permitted by applicable law, any right it may have to a trial
by jury in respect of any litigation directly or indirectly arising out of, under or in connection
with this Agreement. Each party hereto (i) certifies that no representative, agent or attorney of
the other party has represented, expressly or otherwise, that the other party would not, in the
event of litigation, seek to enforce the foregoing waiver and (ii) acknowledges that it and the
other parties hereto have been induced to enter into this Agreement by, among other things, the
mutual waivers and certifications in this Section.

     23. Agreement Governs. This Agreement is to be deemed consistent wherever possible
with relevant provisions of the Company’s Bylaws and Second Amended and Restated Certificate of
Incorporation; however, in the event of a conflict between this Agreement and such provisions, the
provisions of this Agreement shall control.

     24. Mitigation. Indemnitee shall be obligated to use reasonable efforts to mitigate
any liability, loss, costs, claims or damages sustained by it in connection with any matter for
which the Company may have an obligation to indemnify hereunder.

[Signature Page Follows]

8

 

	 	 	 	 	 

          IN WITNESS WHEREOF, the parties hereto have executed this Indemnification Agreement as of the
day and year first above written.

	 	 	 	 	 
	 	3AMLABS, INC.

 	 
	 	By:  	/s/ Michael Simon
 	 
	 	 	Name:  	Michael Simon 	 
	 	 	Title:  	President and CEO 	 
	 
	 	DIRECTOR:

 	 
	 	By:  	/s/ Michael Simon
 	 
	 	 	Michael Simonexv10w13

 

Exhibit 10.13

SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

     THIS SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement”) is made as of
December 26, 2007, by and among LogMeIn, Inc., a Delaware corporation (the “Company”), and each of
the holders of the Company’s Series A Preferred Stock, Series B Preferred Stock and Series B-1
Preferred Stock listed on Schedule A hereto (each, individually, an “Investor”, and collectively,
the “Investors”).

RECITALS

     WHEREAS, pursuant to the Series A Preferred Stock Purchase Agreement, dated as of October 15,
2004, certain of the Investors previously acquired shares of the Company’s Series A Preferred
Stock;

     WHEREAS, pursuant to the Series B Preferred Stock Purchase Agreement, dated as of December 5,
2005, certain of the Investors previously acquired shares of the Company’s Series B Preferred
Stock;

     WHEREAS, the Company and Investors are parties to that certain Amended and Restated Investor
Rights Agreement, dated as of December 5, 2005 (the “Prior Agreement”);

     WHEREAS, the Company and certain of the Investors are parties to that certain Series B-1
Preferred Stock Purchase Agreement as of even date herewith (the “Purchase Agreement”); and

     WHEREAS, in order to induce the Company to enter into the Purchase Agreement and to induce the
Investors that are parties to the Purchase Agreement to invest funds in the Company pursuant to the
Purchase Agreement, the Company and the Investors party hereto (representing at least 60% of the
outstanding Registrable Securities (as defined in the Prior Agreement) hereby agree (i) to amend
and restate the Prior Agreement in its entirety on the terms and conditions contained herein and
(ii) that this Agreement shall govern the rights of the Investors to cause the Company to register
shares of Common Stock issuable to the Investors, to receive certain information from the Company,
to participate in future equity offerings by the Company and certain other matters as set forth in
this Agreement.

     NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:

     1. Definitions. For purposes of this Agreement:

          1.1 The term “Affiliate” shall mean with respect to any individual, corporation, partnership,
association, trust, or any other entity (in each case, a “Person”), any Person which, directly or
indirectly, controls, is controlled by or is under common control with such Person, including,
without limitation any general partner, officer or director of such Person and any venture capital
fund now or hereafter existing which is controlled by or under common control with one or more
general partners or shares the same management company with such Person.

 

 

          1.2 The term “Charter” shall mean the Company’s Fifth Amended and Restated Certificate of
Incorporation, as filed with the Secretary of State of Delaware on or
about December 26, 2007, as
the same may be amended or restated from time to time.

          1.3 The term “Common Stock” shall mean shares of the Company’s common stock, par value $0.01
per share.

          1.4 The term “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder.

          1.5 The term “Form S 3” means such form under the Securities Act as in effect on the date
hereof or any registration form under the Securities Act subsequently adopted by the SEC which
permits inclusion or incorporation of substantial information by reference to other documents filed
by the Company with the SEC.

          1.6 The term “GAAP” shall mean generally accepted accounting principles in the United States.

          1.7 The term “Holder” shall mean any Person owning or having the right to acquire Registrable
Securities or any assignee thereof in accordance with Section 2.12 hereof.

          1.8 The term “Immediate Family Member” shall mean a child, stepchild, grandchild, parent,
stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law,
daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, of a person
referred to herein.

          1.9 The term “Initiating Holders” means, collectively, any Holders who properly initiate a
registration request under this Agreement.

          1.10 The term “Key Employee” means each of Michael Simon, Marton Anka and Jim Kelliher, as
well as any non-executive-level employee who either alone or in concert with others develops,
invents, programs or designs any Company Intellectual Property (as defined in the Purchase
Agreement).

          1.11 The term “Major Investor” means, any Investor that, together with such Investor’s
Affiliates, holds at least 2,200,000 shares of Registrable Securities (appropriately adjusted for
any stock split, dividend, combination or other recapitalization effected after the date hereof).

          1.12 The term “New Securities” shall mean equity securities of the Company, whether now
authorized or not, or rights, options, or warrants to purchase said equity securities, or
securities of any type whatsoever that are, or may become, convertible into or exchangeable into or
exercisable for said equity securities.

          1.13 The term “Preferred Director” means those members of the Company’s Board of Directors
designated and elected by the holders of the Company’s Preferred Stock in accordance with the
Charter and the Voting Agreement.

2

 

          1.14 The term “Preferred Stock” shall mean, collectively, shares of the Company’s Series A
Preferred Stock, Series B Preferred Stock and Series B-1 Preferred Stock.

          1.15 The term “Prior Agreement” shall have the meaning designated in the Recitals of this
Agreement.

          1.16 The term “Qualified IPO” means the closing of the sale of shares of Common Stock to the
public at a price of at least $4.50 per share (subject to appropriate adjustment for stock splits,
stock dividends, combinations and other similar recapitalizations affecting such shares), in a
firm-commitment underwritten public offering pursuant to an effective registration statement under
the Securities Act, resulting in at least $50 million of gross proceeds to the Company.

          1.17 The term “register,” “registered,” and “registration” refer to a registration effected by
preparing and filing a registration statement or similar document in compliance with the Securities
Act, and the declaration or ordering of effectiveness of such registration statement or document.

          1.18 The term “Registrable Securities” means (i) the Common Stock issuable or issued upon
conversion of the Preferred Stock, (ii) any Common Stock of the Company owned by the Investors as
of the date hereof or acquired by the Investors after the date hereof, including, without
limitation, any Common Stock issued or issuable upon conversion of any capital stock of the Company
acquired by the Investors after the date hereof, and (iii) any Common Stock of the Company issued
as (or issuable upon the conversion or exercise of any warrant, right or other security which is
issued as) a dividend or other distribution with respect to, or in exchange for or in replacement
of the shares referenced in clause (i) and (ii) above, excluding in all cases, however, any
Registrable Securities sold by a person in a transaction in which his rights under Section 2 hereof
are not assigned or any shares for which registration rights have terminated pursuant to Section
2.15 of this agreement.

          1.19 The term “Registrable Securities then outstanding” means the number of shares determined
by adding the number of shares of Common Stock outstanding which are, and the number of shares of
Common Stock issuable pursuant to then exercisable or convertible securities which are, Registrable
Securities.

          1.20 The term “SEC” means the Securities and Exchange Commission.

          1.21 The term “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act.

          1.22 The term “SEC Rule 144(k)” means Rule 144(k) promulgated by the SEC under the Securities
Act.

          1.23 The term “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act.

          1.24 The term “Securities Act” means the Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder.

3

 

          1.25 The term “Series A Preferred Stock” means shares of the Company’s Series A Convertible
Preferred Stock, par value $0.01 per share.

          1.26 The term “Series B Preferred Stock” means shares of the Company’s Series B Convertible
Preferred Stock, par value $0.01 per share.

          1.27 The term “Series B-1 Preferred Stock” means shares of the Company’s Series B Convertible
Preferred Stock, par value $0.01 per share.

          1.28 The term “TCEE” shall mean collectively Technologieholding Central and Eastern European
Fund NV and Technologieholding Central and Eastern Europeanparallel Fund BV.

          1.29 The term “Violation” means losses, claims, damages, or liabilities (joint or several) to
which a party hereto may become subject under the Securities Act, the Exchange Act or other federal
or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect
thereof) arise out of or are based upon any of the following statements, omissions or violations:
(i) any untrue statement or alleged untrue statement of a material fact contained in such
registration statement, including any preliminary prospectus or final prospectus contained therein
or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a
material fact required to be stated therein, or necessary to make the statements therein not
misleading, or (iii) any violation or alleged violation by any other party hereto, of the
Securities Act, the Exchange Act, any state securities law or any rule or regulation promulgated
under the Securities Act, the Exchange Act or any state securities law.

          1.30 The term “Voting Agreement” has the meaning set forth in Section 3.3.

     2. Registration Rights. The Company covenants and agrees as follows:

          2.1 Request for Registration.

               (a) If the Company shall receive at any time after (i) four (4) years after the date of this
Agreement or (ii) 180 days after the effective date of the first registration statement for a
public offering of securities of the Company (other than a registration statement relating either
to the sale of securities to employees of the Company pursuant to a stock option, stock purchase or
similar plan or a SEC Rule 145 transaction), if earlier, a written request from the Holders of 60%
of the Registrable Securities then outstanding that the Company file a registration statement under
the Securities Act covering the registration of the Registrable Securities then outstanding, then
the Company shall:

                    (i) within ten (10) days of the receipt thereof, give written notice of such request to all
Holders;

                    (ii) as soon as practicable, and in any event within ninety (90) days of the receipt of such
request, file a registration statement under the Securities Act covering all Registrable Securities
which the Holders request to be registered, subject to the limitations of subsection
2.1(b), within twenty (20) days of the mailing of such notice by the Company in accordance with
Section 6.5; and

4

 

                    (iii) use its best efforts to cause such registration statement to be declared effective by
the SEC as soon as practicable but in no event later than 90 days after such request.

               (b) If the Initiating Holders intend to distribute the Registrable Securities covered by their
request by means of an underwriting, they shall so advise the Company as a part of their request
made pursuant to subsection 2.1(a) and the Company shall include such information in the
written notice referred to in subsection 2.1(a). The underwriter will be selected by the
Initiating Holders subject only to the reasonable approval of the Company. In such event, the
right of any Holder to include such Holder’s Registrable Securities in such registration shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of such
Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders
proposing to distribute their securities through such underwriting shall (together with the Company
as provided in subsection 2.3(e)) enter into an underwriting agreement in customary form
with the underwriter or underwriters selected for such underwriting. Notwithstanding any other
provision of this Section 2.1, if the underwriter advises the Initiating Holders in writing
that marketing factors require a limitation of the number of shares to be underwritten, then the
Initiating Holders shall so advise all Holders of Registrable Securities which would otherwise be
underwritten pursuant hereto, and the number of shares of Registrable Securities that may be
included in the underwriting shall be allocated among all Holders of Registrable Securities,
including the Initiating Holders, in proportion (as nearly as practicable) to the number of
Registrable Securities of the Company owned by each Holder; provided, however, that
the number of shares of Registrable Securities held by the Holders to be included in such
underwriting shall not be reduced unless all other securities are first entirely excluded from the
underwriting. To facilitate the allocation of shares in accordance with the above provisions, the
Company or the underwriters may round the number of shares allocated to any Holder to the nearest
100 shares.

               (c) Notwithstanding the foregoing, if the Company shall furnish to Holders requesting a
registration statement pursuant to this Section 2.1 a certificate signed by the Chief
Executive Officer of the Company stating that in the good faith judgment of the Board of Directors
of the Company it would be materially detrimental to the Company and its stockholders for such
registration statement to become effective or to remain effective as long as such registration
statement would otherwise be required to remain effective because such action (x) would materially
interfere with a significant acquisition, corporate reorganization or other similar transaction
involving the Company, (y) would require premature disclosure of material information that the
Company has a bona fide business purpose for preserving as confidential or (z) would render the
Company unable to comply with requirements under the Securities Act or Exchange Act, the Company
shall have the right to defer taking action with respect to such filing for a period of not more
than one hundred twenty (120) days after receipt of the request of the Initiating Holders;
provided, however, that the Company may not utilize this right more than once in
any twelve-month period and provided, further that the Company shall not register
any securities for the account of itself or any other stockholder during such one hundred twenty
(120) day period other than a registration statement relating either to the sale of securities to
employees of the Company pursuant to a stock option, stock purchase or similar plan or an SEC Rule
145 transaction, a registration on any form that does not include substantially the same
information as would be required to be included in a registration statement covering the sale of
the Registrable

5

 

Securities, or a registration in which the only Common Stock being registered is Common Stock
issuable upon conversion of debt securities that are also being registered).

               (d) Notwithstanding anything in this Section 2.1 to the contrary, the Company shall not be
required to consummate more than two (2) offerings pursuant to this Section 2.1.

     A registration statement shall not be counted until such time as such registration statement
has been declared effective by the SEC (unless the Initiating Holders withdraw their request for
such registration (other than as a result of information concerning the business or financial
condition of the Company which is made known to the Investors after the date on which such
registration was requested) and elect not to pay the registration expenses therefor pursuant to
Section 2.5). A registration statement shall not be counted if, as a result of an exercise
of the underwriter’s cut-back provisions, fewer than 50% of the total number of Registrable
Securities that Holders have requested to be included in such registration statement are actually
included.

          2.2 Company Registration. If the Company proposes to register (including for this
purpose a registration effected by the Company for stockholders other than the Holders) any of its
stock or other securities under the Securities Act in connection with the public offering of such
securities solely for cash (other than a registration statement relating either to the sale of
securities to employees of the Company pursuant to a stock option, stock purchase or similar plan
or an SEC Rule 145 transaction, a registration on any form which does not include substantially the
same information as would be required to be included in a registration statement covering the sale
of the Registrable Securities or a registration in which the only Common Stock being registered is
Common Stock issuable upon conversion of debt securities which are also being registered), the
Company shall, at such time, promptly give each Holder written notice of such registration. Upon
the written request of each Holder given within twenty (20) days after mailing of such notice by
the Company in accordance with Section 6.5, the Company shall, subject to the provisions of
Section 2.7, cause to be registered under the Securities Act all of the Registrable
Securities that each such Holder has requested to be registered. The Company shall have the right
to terminate or withdraw any registration initiated by it under this Section 2.2 prior to
the effectiveness of such registration whether or not any Holder has elected to include securities
in such registration. The expenses of such withdrawn registration shall be borne by the Company in
accordance with Section 2.6 hereof.

          2.3 Obligations of the Company. Whenever required under this Section 2 to
effect the registration of any Registrable Securities, the Company shall, as expeditiously as
reasonably possible,

               (a) prepare and file with the SEC a registration statement with respect to such Registrable
Securities and use its reasonable best efforts to cause such registration statement to become
effective, and, upon the request of the Holders of a majority of the Registrable Securities
registered thereunder, keep such registration statement effective for a period of up to one hundred
twenty (120) days or, if earlier, until the distribution contemplated in the Registration Statement
has been completed; provided, however, that (i) such 120-day period shall be
extended for a period of time equal to the period the Holder refrains from selling any

6

 

securities included in such registration at the request of an underwriter of Common Stock (or
other securities) of the Company; and (ii) in the case of any registration of Registrable
Securities on Form S-3 that are intended to be offered on a continuous or delayed basis, subject to
compliance with applicable SEC rules, such 120-day period shall be extended as necessary, to keep
the registration statement effective until all such Registrable Securities are sold;

               (b) prepare and file with the SEC such amendments and supplements to such registration
statement and the prospectus used in connection with such registration statement as may be
necessary to comply with the provisions of the Securities Act with respect to the disposition of
all securities covered by such registration statement;

               (c) furnish to the Holders such numbers of copies of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Securities Act, and such other documents as
they may reasonably request in order to facilitate the disposition of Registrable Securities owned
by them;

               (d) use its reasonable best efforts to register and qualify the securities covered by such
registration statement under such other securities or Blue Sky laws of such jurisdictions as shall
be reasonably requested by the Holders; provided that the Company shall not be required in
connection therewith or as a condition thereto to qualify to do business or to file a general
consent to service of process in any such states or jurisdictions, unless the Company is already
subject to service in such jurisdiction and except as may be required by the Securities Act;

               (e) in the event of any underwritten public offering, enter into and perform its obligations
under an underwriting agreement, in usual and customary form, with the managing underwriter of such
offering. Each Holder participating in such underwriting shall also enter into and perform its
obligations under such an agreement;

               (f) cause all such Registrable Securities registered pursuant to this Agreement hereunder to
be listed on a national securities exchange or trading system and each securities exchange and
trading system on which similar securities issued by the Company are then listed;

               (g) provide a transfer agent and registrar for all Registrable Securities registered pursuant
hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the
effective date of such registration; and

               (h) use its reasonable best efforts to furnish, at the request of any Holder requesting
registration of Registrable Securities pursuant to this Section 2, on the date on which
such Registrable Securities are sold to the underwriter, (i) an opinion, dated such date, of the
counsel representing the Company for the purposes of such registration, in form and substance as is
customarily given to underwriters in an underwritten public offering, addressed to the
underwriters, if any, and (ii) a “comfort” letter dated such date, from the independent certified
public accountants of the Company, in form and substance as is customarily given by independent
certified public accountants to underwriters in an underwritten public offering, addressed to the
underwriters, if any.

7

 

          2.4 Furnish Information. (a) It shall be a condition precedent to the obligations of
the Company to take any action pursuant to this Section 2 with respect to the Registrable
Securities of any selling Holder that such Holder shall furnish to the Company such information
regarding itself, the Registrable Securities held by it, and the intended method of disposition of
such securities as shall be reasonably required to effect the registration of such Holder’s
Registrable Securities.

          2.5 Expenses of Demand Registration. All expenses other than underwriting discounts
and commissions incurred in connection with registrations, filings or qualifications pursuant to
Section 2.1, including (without limitation) all registration, filing and qualification
fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and the
reasonable fees and disbursements of one counsel for all of the selling Holders (such legal fees
not to exceed $35,000), collectively, shall be borne by the Company; provided, however, that the
Company shall not be required to pay for any expenses of any registration proceeding begun pursuant
to Section 2.1 if the registration request is subsequently withdrawn at the request of the
Holders of a majority of the Registrable Securities to be registered (in which case all
participating Holders shall bear such expenses pro rata based upon the number of Registrable
Securities that were to be included in the withdrawn registration), unless the Holders of a
majority of the Registrable Securities agree to forfeit their right to one demand registration
pursuant to Section 2.1; provided further, however, that if at the time of such withdrawal,
the Holders have learned of a material adverse change in the condition, business, or prospects of
the Company from that known to the Holders at the time of their request and have withdrawn the
request with reasonable promptness after learning of such information, then the Holders shall not
be required to pay any of such expenses and shall retain their rights pursuant to Section
2.1.

          2.6 Expenses of Company Registration. The Company shall bear and pay all expenses
incurred in connection with any registration, filing or qualification of Registrable Securities
with respect to the registrations pursuant to Section 2.2 hereof for each Holder (which
right may be assigned as provided in Section 2.12 hereof), including (without limitation)
all registration, filing, and qualification fees, printers and accounting fees relating or
apportionable thereto and the reasonable fees and disbursements of one counsel for all of the
selling Holders, collectively, selected by them, but excluding underwriting discounts and
commissions relating to Registrable Securities.

          2.7 Underwriting Requirements. In connection with any offering involving an
underwriting of shares of the Company’s capital stock pursuant to Section 2.2, the Company
shall not be required to include any of the Holders’ securities in such underwriting unless they
accept the terms of the underwriting as agreed upon between the Company and its underwriters, and
then only in such quantity as the underwriters determine in their sole discretion will not
jeopardize the success of the offering by the Company. If the total number of securities,
including Registrable Securities, requested by stockholders to be included in such offering exceeds
the amount of securities to be sold other than by the Company that the underwriters determine in
their reasonable discretion is compatible with the success of the offering, then the Company shall
be required to include in the offering only that number of such securities, including Registrable
Securities, which the underwriters and the Company determine in their sole discretion will not
jeopardize the success of the offering. In no event shall any Registrable Securities be excluded
from such offering unless all other stockholders’ securities have been first

8

 

excluded. In the event that the underwriters determine that less than all of the Registrable
Securities requested to be registered can be included in such offering, then the Registrable
Securities that are included in such offering shall be apportioned pro rata among the selling
Holders based on the number of Registrable Securities held by all selling Holders or in such other
proportions as shall mutually be agreed to by all such selling Holders. Notwithstanding the
foregoing, in no event shall the amount of securities of the selling Holders included in the
offering be reduced below thirty percent (30%) of the total amount of securities included in such
offering, unless such offering is the Company’s IPO in which case the selling Holders may be
excluded beyond this amount if the underwriters make the determination described above and no other
stockholder’s securities be included in such offering. For purposes of the preceding parenthetical
concerning apportionment, for any selling stockholder which is a Holder of Registrable Securities
and which is an investment fund, partnership, limited liability company or corporation, the
partners, members, retired partners, retired members, stockholders and Affiliates of such Holder,
or the estates and family members of any such partners, retired partners, members and retired
members and any trusts for the benefit of any of the foregoing persons shall be deemed to be a
single “selling Holder”, and any pro-rata reduction with respect to such “selling Holder” shall be
based upon the aggregate amount of shares carrying registration rights owned by all entities and
individuals included in such “selling Holder,” as defined in this sentence.

          2.8 Delay of Registration. No Holder shall have any right to obtain or seek an
injunction restraining or otherwise delaying any registration pursuant to this Agreement as the
result of any controversy that might arise with respect to the interpretation or implementation of
this Section 2.

          2.9 Indemnification. In the event any Registrable Securities are included in a
registration statement under this Section 2:

               (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder,
the partners, members, officers, directors and stockholders of each Holder, legal counsel and
accountants for each Holder, any underwriter (as defined in the Securities Act) for such Holder and
each person, if any, who controls such Holder or underwriter within the meaning of the Securities
Act or the Exchange Act, against any Violation and the Company will pay to each such Holder,
underwriter, controlling person or other aforementioned person, any legal or other expenses
reasonably incurred by them in connection with investigating or defending any such loss, claim,
damage, liability, or action as such expenses are incurred; provided, however, that
the indemnity agreement contained in this subsection 2.9(a) shall not apply to amounts paid
in settlement of any such loss, claim, damage, liability, or action if such settlement is effected
without the consent of the Company (which consent shall not be unreasonably withheld), nor shall
the Company be liable in any such case for any such loss, claim, damage, liability, or action to
the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in
conformity with written information furnished expressly for use in connection with such
registration by any such Holder, underwriter, controlling person or other aforementioned person.

               (b) To the extent permitted by law, each selling Holder will severally and not jointly
indemnify and hold harmless the Company, each of its directors, each of its

9

 

officers who has signed the registration statement, each person, if any, who controls the
Company within the meaning of the Securities Act, legal counsel and accountants for the Company,
any underwriter, any other Holder selling securities in such registration statement and any
controlling person of any such underwriter or other Holder, against any losses, claims, damages, or
liabilities (joint or several) to which any of the foregoing persons may become subject, under the
Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims,
damages, or liabilities (or actions in respect thereto) arise out of or are based upon any
Violation, in each case to the extent (and only to the extent) that such Violation occurs in
reliance upon and in conformity with written information furnished by such Holder expressly for use
in connection with such registration; and each such Holder will pay, any legal or other expenses
reasonably incurred by any person intended to be indemnified pursuant to this subsection
2.9(b), in connection with investigating or defending any such loss, claim, damage, liability,
or action; provided, however, that the indemnity agreement contained in this
subsection 2.9(b) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability or action if such settlement is effected without the consent of the Holder, which
consent shall not be unreasonably withheld; provided, further, that, in no event shall any
indemnity under this subsection 2.9(b) exceed the net proceeds from the offering received
by such Holder, except in the case of fraud or willful misconduct by such Holder.

               (c) Promptly after receipt by an indemnified party under this Section 2.9 of notice of
the commencement of any action (including any governmental action), such indemnified party will, if
a claim in respect thereof is to be made against any indemnifying party under this Section
2.9, deliver to the indemnifying party a written notice of the commencement thereof and the
indemnifying party shall have the right to participate in, and, to the extent the indemnifying
party so desires, jointly with any other indemnifying party similarly noticed, to assume the
defense thereof with counsel mutually satisfactory to the parties; provided,
however, that an indemnified party (together with all other indemnified parties which may
be represented without conflict by one counsel) shall have the right to retain one separate
counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such
indemnified party by the counsel retained by the indemnifying party would be inappropriate due to
actual or potential differing interests between such indemnified party and any other party
represented by such counsel in such proceeding.

               (d) In order to provide for just and equitable contribution to joint liability under the
Securities Act in any case in which either (i) any Holder exercising rights under this Agreement,
or any controlling person of any such Holder, makes a claim for indemnification pursuant to this
Section 2.9 but it is judicially determined (by the entry of a final judgment or decree by
a court of competent jurisdiction and the expiration of time to appeal or the denial of the last
right of appeal) that such indemnification may not be enforced in such case notwithstanding the
fact that this Section 2.9 provides for indemnification in such case, or (ii) contribution
under the Securities Act may be required on the part of any such selling Holder or any such
controlling person in circumstances for which indemnification is provided under this Section
2.9, then, and in each such case, the Company and such Holder will contribute to the aggregate
losses, claims, damages or liabilities to which they may be subject (after contribution from
others) in such proportion as is appropriate to reflect the relative fault of the indemnifying
party on the one hand and of the indemnified party on the other in connection with the statements
or omissions that resulted in such loss, liability, claim, damage, or expense as well as any other

10

 

relevant equitable considerations. The relative fault of the indemnifying party and of the
indemnified party shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission to state a material
fact relates to information supplied by the indemnifying party or by the indemnified party and the
parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent
such statement or omission; provided, however, that, in any such case, (I) no such
Holder will be required to contribute any amount in excess of the aggregate public offering price
of all such Registrable Securities offered and sold by such Holder pursuant to such registration
statement, and (II) no person or entity guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity
who was not guilty of such fraudulent misrepresentation; provided, further, that in
no event shall a Holder’s liability pursuant to this Section 2.9(d), when combined with the
amounts paid or payable by such holder pursuant to Section 2.9(b), exceed the proceeds from
the offering (net of any underwriting discounts or commissions) received by such Holder, except in
the case of willful fraud by such Holder.

               (e) Unless otherwise superceded by an underwriting agreement entered into in connection with
the underwritten public offering, the obligations of the Company and Holders under this Section
2.9 shall survive the completion of any offering of Registrable Securities in a registration
statement under this Section 2, and otherwise and shall survive the termination of this
Agreement.

          2.10 Reports Under Exchange Act. With a view to making available to the Holders the
benefits of SEC Rule 144 promulgated under the Securities Act and any other rule or regulation of
the SEC that may at any time permit a Holder to sell securities of the Company to the public
without registration or pursuant to a registration on Form S 3, the Company agrees to:

               (a) make and keep public information available, as those terms are understood and defined in
SEC Rule 144, at all times after the effective date of the first registration statement filed by
the Company for the offering of its securities to the general public so long as the Company is
subject to the periodic reporting requirements under Sections 13 or 15(d) of the Exchange Act;

               (b) file with the SEC in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act; and

               (c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith
upon request (i) a written statement by the Company that it has complied with the reporting
requirements of SEC Rule 144, the Securities Act and the Exchange Act (at any time after it has
become subject to such reporting requirements), or that it qualifies as a registrant whose
securities may be resold pursuant to Form S 3 (at any time after it so qualifies), (ii) a copy of
the most recent annual or quarterly report of the Company and such other reports and documents so
filed by the Company, and (iii) such other information as may be reasonably requested in availing
any Holder of any rule or regulation of the SEC which permits the selling of any such securities
without registration or pursuant to such form.

11

 

          2.11 Form S 3 Registration. In case the Company shall receive from Holders of at
least 10% of all Registrable Securities then outstanding a written request or requests that the
Company effect a registration on Form S 3 and any related qualification or compliance with respect
to all or a part of the Registrable Securities owned by such Holder or Holders, the Company will:

               (a) promptly give written notice of the proposed registration, and any related qualification
or compliance, to all other Holders; and

               (b) as soon as practicable, effect such registration and all such qualifications and
compliances as may be so requested and as would permit or facilitate the sale and distribution of
all or such portion of such Holder’s or Holders’ Registrable Securities as are specified in such
request, together with all or such portion of the Registrable Securities of any other Holder or
Holders joining in such request as are specified in a written request given within 15 days after
receipt of such written notice from the Company; provided, however, that the
Company shall not be obligated to effect any such registration, qualification or compliance,
pursuant to this Section 2.11: (1) if Form S 3 is not then available for such offering by
the Holders; (2) if the Holders, together with the holders of any other securities of the Company
entitled to inclusion in such registration, propose to sell Registrable Securities and such other
securities (if any) at an aggregate price to the public (net of any underwriters’ discounts or
commissions) of less than $1 million; (3) if the Company shall furnish to the Holders a certificate
signed by the President of the Company stating that in the good faith judgment of the Board of
Directors of the Company, it would be materially detrimental to the Company and its stockholders
for such Form S 3 Registration to be effected at such time, in which event the Company shall have
the right to defer the filing of the Form S 3 registration statement for a period of not more than
sixty (60) days after receipt of the request of the Holder or Holders under this Section
2.11; provided, however, that the Company shall not utilize this right more
than once in any twelve month period and provided, further, that the Company shall
not register any securities for the account of itself or any other stockholder during such sixty
day period (other than a registration relating solely to the sale of securities of participants in
a Company stock plan, a registration relating to a corporate reorganization or transaction under
Rule 145 of the Securities Act, a registration on any form that does not include substantially the
same information as would be required to be included in a registration statement covering the sale
of the Registrable Securities, or a registration in which the only Common Stock being registered is
Common Stock issuable upon conversion of debt securities that are also being registered); (4) if
the Company has, within the twelve (12) month period preceding the date of such request, already
effected two registrations on Form S 3 for the Holders pursuant to this Section 2.11; or
(5) in any particular jurisdiction in which the Company would be required to qualify to do business
or to execute a general consent to service of process in effecting such registration, qualification
or compliance.

               (c) Subject to the foregoing, the Company shall file a registration statement covering the
Registrable Securities and other securities so requested to be registered as soon as practicable
after receipt of the request or requests of the Holders. All expenses incurred in connection with
a registration requested pursuant to Section 2.11, including (without limitation) all
registration, filing, qualification, printer’s and accounting fees and the reasonable fees and
disbursements of one counsel for all of the selling Holder or Holders and counsel for the

12

 

Company, but excluding any underwriters’ discounts or commissions associated with Registrable
Securities, shall be borne by the Company. Registrations effected pursuant to this Section
2.11 shall not be counted as demands for registration or registrations effected pursuant to
Sections 2.1.

               (d) If the Initiating Holders intend to distribute the Registrable Securities covered by their
request by means of an underwriting, they shall so advise the Company as part of their request made
pursuant to this Section 2.11 and the Company shall include such information in the written
notice referred to in Section 2.11(a). The provisions of Section 2.1(b) shall be
applicable to such request (with the substitution of Section 2.11 for references to
Section 2.1).

          2.12 Assignment of Registration Rights. The rights to cause the Company to register
Registrable Securities pursuant to this Section 2 may be assigned (but only with all
related obligations) by a Holder to a transferee or assignee of such securities that (i) is a
subsidiary, Affiliate, parent, partner, member, limited partner, retired partner, retired member or
stockholder of a Holder, (ii) is a Holder’s family member or trust for the benefit of an individual
Holder or such Holder’s family member, or (iii), after such assignment or transfer, holds at least
ten percent (10%) of the Registrable Securities (subject to appropriate adjustment for stock
splits, stock dividends, combinations and other recapitalizations) it purchased under the Original
Purchase Agreement and is purchasing under the Purchase Agreement, provided: (a) the Company is,
within a reasonable time after such transfer, furnished with written notice of the name and address
of such transferee or assignee and the securities with respect to which such registration rights
are being assigned; (b) such transferee or assignee agrees in writing to be bound by and subject to
the terms and conditions of this Agreement, including without limitation the provisions of
Section 2.14 below; (c) such assignment shall be effective only if immediately following
such transfer the further disposition of such securities by the transferee or assignee is
restricted under the Securities Act; and (d) such transferee or assignee is not a competitor of the
Company, as determined in good faith by the Board of Directors. For the purposes of determining
the number of shares of Registrable Securities held by a transferee or assignee, the holdings of
transferee or assignee (i) that is a subsidiary, parent, partner, limited partner, retired partner,
member, retired member or stockholder of a Holder; (ii) that is an Affiliate of the Holder, which
means with respect to a limited liability company or a limited liability partnership, a fund or
entity managed by the same manager or managing member or general partner or management company or
by an entity controlling, controlled by, or under common control with such manager or managing
member or general partner or management company, (iii) who is a Holder’s Immediate Family Member,
(iv) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family
Member, shall be aggregated together and with those of the assigning Holder; provided that all
assignees and transferees who would not qualify individually for assignment of registration rights
shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices or
taking any action under this Section 2.

          2.13 Limitations on Subsequent Registration Rights. From and after the date of this
Agreement, the Company shall not, without the prior written consent of the Holders of a 60% of the
Registrable Securities then outstanding, enter into any agreement with any holder or prospective
holder of any securities of the Company which would allow such holder or prospective holder (a) to
include such securities in any registration unless under the terms of such agreement, such holder
or prospective holder may include such securities in any such

13

 

registration only to the extent that the inclusion of such securities will not reduce the
amount of the Registrable Securities of the Holders that are included or (b) to demand registration
of any securities held by such holder or prospective holder.

          2.14 “Market Stand Off” Agreement. Each Holder hereby agrees that it will not,
without the prior written consent of the managing underwriter, during the period commencing on the
date of the final prospectus relating to the Company’s IPO and ending on the date specified by the
Company and the managing underwriter (such period not to exceed one hundred eighty (l80) days) (i)
lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer
or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible
into or exercisable or exchangeable for Common Stock (whether such shares or any such securities
are then owned by the Holder or are thereafter acquired) held immediately prior to the
effectiveness of the Registration Statement for such offering, or (ii) enter into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of
ownership of the Common Stock, whether any such transaction described in clause (i) or (ii) above
is to be settled by delivery of Common Stock or other securities, in cash or otherwise (any of the
foregoing actions described in foregoing clauses (i) and (ii), hereinafter, a “Transfer”);
provided, however, nothing in this Section 2.14 shall restrict or prohibit
the Transfer by any Holder of any shares of Common Stock (x) sold in the Company’s IPO pursuant to
the registration rights provided under this Agreement, (y) purchased in the Company’s IPO, or (z)
purchased in the public market following the Company’s IPO. The foregoing provisions of this
Section 2.14 shall apply only to the Company’s IPO, shall not apply to the sale of any
shares to an underwriter pursuant to an underwriting agreement, and shall only be applicable to the
Holders if all officers, directors and greater than one percent (1%) stockholders of the Company
enter into similar agreements. The underwriters in connection with the Company’s IPO are intended
third party beneficiaries of this Section 2.14 and shall have the right, power and
authority to enforce the provisions hereof as though they were a party hereto. Each Holder further
agrees to execute such agreements as may be reasonably requested by the underwriters in the
Company’s IPO that are consistent with this Section 2.14 or that are necessary to give
further effect thereto. Any discretionary waiver or termination of the restrictions of any or all
of such agreements by the Company or the underwriters shall apply to all Holders subject to such
agreements pro rata based on the number of shares subject to such agreements.

     In order to enforce the foregoing covenant, the Company may impose stop transfer instructions
with respect to the Registrable Securities of each Holder (and the shares or securities of every
other person subject to the foregoing restriction) until the end of such period.

          2.15 Termination of Registration Rights. No Holder shall be entitled to exercise any
right provided for in this Section 2 at anytime after (a) five (5) years following the
consummation of a Qualified IPO. Except for the Investor’s obligations under Section 2.14,
all other provisions of this Section 2 shall terminate and expire as to any Investor whose
shares of Preferred Stock are converted into Common Stock pursuant to special mandatory conversion
provisions set forth in Article Fourth, Section B.5A of the Charter upon such special mandatory
conversion. Except for purposes of Section 2.14 and Section 3.5, following any
such

14

 

termination, such Investor shall no longer be deemed an “Investor” for any purpose of this
Agreement.

     3. Information and Observer Rights.

          3.1 Delivery of Financial Statements. The Company shall deliver to each Major
Investor:

               (a) as soon as practicable, but in any event within one hundred twenty (120) days after the
end of each fiscal year of the Company, a balance sheet and income statement as of the last day of
such year; a statement of cash flows for such year and a comparison between the actual figures for
such year, the comparable figures for the prior year and the comparable figures included in the
Budget (as defined below) for such year, with an explanation of any material differences between
them and a schedule as to the sources and applications of funds for such year, such year end
financial reports to be in reasonable detail, prepared in accordance with GAAP, (except that the
financial report may (i) be subject to normal year-end audit adjustments and (ii) not contain all
notes thereto which may be required in accordance with GAAP) and audited and certified by
independent public accountants of nationally recognized standing selected by the Company;

               (b) as soon as practicable, but in any event within forty five (45) days after the end of each
of the first three (3) quarters of each fiscal year of the Company, an unaudited income statement,
schedule as to the sources and application of funds for such fiscal quarter, an unaudited balance
sheet and a statement of stockholder’s equity as of the end of such fiscal quarter;

               (c) as soon as practicable, but in any event with forty-five (45) days after the end of each
of the first three (3) quarters of each fiscal year of the Company, a statement showing the number
of shares of each class and series of capital stock and securities convertible into or exercisable
for shares of capital stock outstanding at the end of the period, the number of common shares
issuable upon conversion or exercise of any outstanding securities convertible or exercisable for
common shares and the exchange ratio or exercise price applicable thereto and number of shares of
issued stock options and stock options not yet issued but reserved for issuance, if any, all in
sufficient detail as to permit the Major Investors to calculate its percentage equity ownership in
the Company and certified by the Chief Financial Officer or Chief Executive Officer of the Company
as being true, complete and correct;

               (d) as soon as practicable, but in any event within thirty (30) days of the end of each month,
an unaudited income statement, an unaudited profit or loss statement, provided that the obligation
to deliver such monthly financials shall be deemed satisfied with respect to any Major Investor if
such financials are delivered to such Major Investor’s Board of Directors-designee, if any;

               (e) as soon as practicable, but in any event thirty (30) days prior to the end of each fiscal
year, a budget and business plan for the next fiscal year (collectively, the “Budget”), prepared on
a monthly basis, including balance sheets and sources and applications of

15

 

funds statements for such months and, as soon as prepared, any other budgets or revised
budgets prepared by the Company;

               (f) with respect to the financial statements called for in subsections (a), (b) and
(d) of this Section 3.1, an instrument executed by the Chief Financial Officer and
President or Chief Executive Officer of the Company and certifying that such financials were
prepared in accordance with GAAP consistently applied with prior practice for earlier periods (with
the exception of footnotes that may be required by GAAP) and fairly present the financial condition
of the Company and its results of operation for the periods specified therein, subject to year end
audit adjustment;

               (g) such other information relating to the financial condition, business, prospects or
corporate affairs of the Company as the Major Investor or any assignee of the Major Investor may
from time to time reasonably request, provided, however, that the Company shall not
be obligated under this subsection (g) or any other subsection of Section 3.1 to
(i) provide information which the Company reasonably deems in good faith to be a trade secret or
similar confidential information (unless covered by an enforceable confidentiality agreement, in
form reasonably acceptable to the Company) or (ii) would adversely affect the attorney-client
privilege between the Company and its counsel;

               (h) if for any period the Company shall have any subsidiary whose accounts are consolidated
with those of the Company, then in respect of such period the financial statements delivered
pursuant to the foregoing sections shall be the consolidated and consolidating financial statements
of the Company and all such consolidated subsidiaries; and

               (i) Notwithstanding anything else in this Section 3.1 to the contrary, the Company may
cease providing the information set forth in this Section 3.1 during the period starting
with the date ninety (90) days prior to the Company’s good faith estimate of the date of filing of,
and ending on the effective date of the registration effecting the IPO; provided that the
Company is actively employing its reasonable best efforts to cause such registration statement to
become effective.

          3.2 Inspection. The Company shall permit each Major Investor, at such Major
Investor’s expense, to visit and inspect the Company’s properties, to examine its books of account
and records and to discuss the Company’s affairs, finances and accounts with its officers, all at
such reasonable times as may be reasonably requested by the Major Investor; provided,
however, that the Company shall not be obligated pursuant to this Section 3.2 to
provide access to any information which it reasonably considers to be a trade secret or similar
confidential information or would adversely affect the attorney-client privilege between the
Company and its counsel.

          3.3 Observer Rights. As long as Integral Capital Partners and its affiliated funds
(i) own in the aggregate not less than 1,216,543 of the shares of the Preferred Stock it has
purchased as of the date hereof (or an equivalent amount of Common Stock issued upon conversion
thereof), and (ii) are not entitled to designate a number of the Company’s Board of Directors
pursuant to that certain Second Amended and Restated Voting Agreement dated as of the date hereof
by and among the Company and certain of its stockholders, as the same may be

16

 

amended and restated from time to time (the “Voting Agreement”), the Company shall invite a
representative of Integral Capital Partners to attend all meetings of its Board of Directors in a
nonvoting observer capacity and, in this respect, shall give such representative copies of all
notices, minutes, consents, and other materials that it provides to its directors at the same time
and in the same manner as provided to such directors. As long as TCEE and its affiliated funds (i)
own in the aggregate not less than 2,161,379 shares of the Preferred Stock it has purchased
as of the date hereof (or an equivalent amount of Common Stock issued upon conversion thereof), and
(ii) are not entitled to designate a member of the Company’s Board of Directors pursuant to the
Voting Agreement, the Company shall invite a representative of TCEE to attend all meetings of its
Board of Directors in a nonvoting observer capacity and, in this respect, shall give such
representative copies of all notices, minutes, consents, and other materials that it provides to
its directors at the same time and in the same manner as provided to such directors. Each of the
foregoing representatives shall hold in confidence and trust and to act in a fiduciary manner with
respect to all information provided pursuant this Section 3.3, and, the Company reserves
the right to withhold any information and to exclude such representatives from any meeting or
portion thereof if access to such information or attendance at such meeting could adversely affect
the attorney-client privilege between the Company and its counsel or to protect information the
Company reasonably deems in good faith to be a trade secret or similar confidential information.

          3.4 Termination of Information, Inspection and Observer Covenants. The covenants set
forth in Section 3.1, Section 3.2 and Section 3.3 shall terminate as to
Investors and be of no further force or effect immediately prior to the consummation of the sale of
shares of Common Stock when the Company first becomes subject to the periodic reporting
requirements of Sections 12(g) or 15(d) of the Exchange Act or upon a Deemed Liquidation Event, as
such term is defined in the Charter, whichever event shall first occur. With the exception of
Section 3.5, the provisions of this Section 3 shall terminate and expire as to any
Investor whose shares of Preferred Stock are converted into Common Stock pursuant to special
mandatory conversion provisions set forth in Article Fourth, Section B.5A of the Charter upon such
special mandatory conversion. Except for purposes of Section 2.14 and Section 3.5,
following any such termination, such Investor shall no longer be deemed an “Investor” for any
purpose of this Agreement.

          3.5 Confidentiality. Each Investor (other than Intel Capital Corporation) agrees that
such Investor will keep confidential and will not disclose, divulge or use for any purpose, other
than to monitor its investment in the Company, any confidential information obtained from the
Company pursuant to the terms of this Agreement, unless such confidential information (i) is known
or becomes known to the public in general (other than as a result of a breach of this Section
3.5 by such Investor), (ii) is or has been independently developed or conceived by the Investor
without use of the Company’s confidential information or (iii) is or has been made known or
disclosed to the Investor by a third party without a breach of any obligation of confidentiality
such third party may have to the Company; provided, however, that a Investor may
disclose confidential information (a) to its attorneys, accountants, consultants, and other
professionals to the extent necessary to obtain their services in connection with monitoring its
investment in the Company, (b) to any prospective investor of any Registrable Securities from such
Investor as long as such prospective investor agrees in writing prior to such disclosure to be
bound by the provisions of this Section 3.5, (c) to any Affiliate, partner, member,
stockholder or wholly owned subsidiary of such Investor in the ordinary course of business, or (d)
as may

17

 

otherwise be required by law, provided that the Investor takes reasonable steps to minimize
the extent of any such required disclosure. The Company acknowledges that at least some of the
Investors are in the business of venture capital investing and therefore review the business plans
and related proprietary information of many enterprises, including enterprises which may have
products or services which compete directly or indirectly with those of the Company. Subject to
this Section 3.5, nothing in this Agreement shall preclude or in any way restrict the Investors
from investing or participating in any particular enterprise whether or not such enterprise has
products or services which compete with those of the Company.

     4. Right of First Offer.

          4.1 Right of First Offer. Subject to the terms and conditions specified in this
Section 4.1, and applicable securities laws, in the event the Company proposes to offer or
sell any New Securities, the Company shall first make an offering of such New Securities to each
Investor in accordance with the following provisions of this Section 4.1. A Investor shall
be entitled to apportion the right of first offer hereby granted it among itself and its partners,
members and Affiliates in such proportions as it deems appropriate.

               (a) The Company shall deliver a notice, in accordance with the provisions of Section
6.5 hereof, (the “Offer Notice”) to each of the Investors stating (i) its bona fide intention
to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the
price and terms, if any, upon which it proposes to offer such New Securities.

               (b) By written notification received by the Company, within twenty (20) calendar days after
mailing of the Offer Notice, each of the Investors may elect to purchase or obtain, at the price
and on the terms specified in the Offer Notice, up to that portion of such New Securities which
equals the proportion that the number of then issued and outstanding shares of Common Stock
(including shares of Common Stock issuable upon conversion of shares of the Preferred Stock held by
such Investor) then held by such Investor bears to the total number of then issued and outstanding
shares of Common Stock of the Company (including shares of Common Stock issuable upon conversion
of all shares of the Preferred Stock). The Company shall promptly, in writing, inform each
Investor that elects to purchase all the shares available to it (each, a “Fully Exercising
Investor”) of any other Investor’s failure to do likewise. During the ten (10) day period
commencing after receipt of such information, each Fully Exercising Investor shall be entitled to
obtain that portion of the New Securities for which Investors were entitled to subscribe but which
were not subscribed for by the Investors which is equal to the proportion that the number of shares
of Common Stock issued and held, or issuable upon conversion of the Preferred Stock then held, by
such Fully Exercising Investor bears to the total number of shares of Common Stock issued and held,
or issuable upon conversion of the Preferred Stock then held, by all Fully Exercising Investors who
wish to purchase such unsubscribed shares.

               (c) If all New Securities referred to in the Offer Notice are not elected to be purchased or
obtained as provided in Section 4.1(b) hereof, the Company may, during the ninety (90) day
period following the expiration of the period provided in Section 4.1(b) hereof, offer the
remaining unsubscribed portion of such New Securities (collectively, the “Refused Securities”) to
any person or persons at a price not less than, and upon terms no more favorable

18

 

to the offeree than, those specified in the Offer Notice. If the Company does not enter into
an agreement for the sale of the New Securities within such period, or if such agreement is not
consummated within thirty (30) days of the execution thereof, the right provided hereunder shall be
deemed to be revived and such New Securities shall not be offered unless first reoffered to the
Investors in accordance with this Section 4.1.

               (d) The right of first offer in this Section 4.1 shall not be applicable to: (i)
shares of Common Stock issued or deemed issued to employees or directors of, or consultants to, the
Company or any of its subsidiaries pursuant to any Company equity incentive plan approved by the
Board of Directors of the Company; (ii) shares of Common Stock issued in an IPO; (iii) the issuance
of securities pursuant to the conversion or exercise of convertible or exercisable securities
outstanding on the date hereof; (iv) securities issued in connection with any stock split or stock
dividend of the Company; (v) shares of Common Stock issued or deemed issued in connection with a
financing by bank, equipment lessors or other lending institutions, provided any such financing is
approved by the Board of Directors of the Company, such approval to include the approval of each of
the Preferred Directors then in office; or (vi) shares of Common Stock issued or deemed issued
solely in consideration for the acquisition (whether by merger or otherwise) by the Company or any
of its subsidiaries of all or substantially all of the stock or assets of any other person or
entity, provided any such acquisition is approved by the Board of Directors of the Company, such
approval to include the approval of each of the Preferred Directors then in office or (vii) the
issuance of Series B-1 Preferred Stock pursuant to the Purchase Agreement.

               (e) The right of first offer set forth in this Section 4.1 may not be assigned or
transferred except that (i) such right is assignable by each Investor to any Affiliate of such
Investor, and (ii) such right is assignable by any Investor to any other Investor.

          4.2 Termination. The provisions of this Section 4 shall terminate upon the
earlier of: (a) the consummation of a Qualified IPO, (b) upon a Deemed Liquidation Event, as such
term is defined in the Charter, and (c) on the first date on which less than 4,300,000 shares of
Preferred Stock remain outstanding. The provisions of this Section 4 shall terminate and
expire as to any Investor whose shares of Preferred Stock are converted into Common Stock pursuant
to special mandatory conversion provisions set forth in Article Fourth, Section B.5A of the Charter
upon such special mandatory conversion. Except for purposes of Section 2.14 and
Section 3.5, following any such termination, such Investor shall no longer be deemed an
“Investor” for any purpose of this Agreement.

     5. Additional Covenants.

          5.1 Insurance. The Company shall maintain from financially sound and reputable
insurers (i) insurance coverage on the Company’s property and business, including without
limitation, insurance against liability and the perils of casualty, fire, business interruption,
and extended coverage in commercially reasonable amounts of coverage to the extent customarily
maintained by companies in the same or similar business, and of similar size, as the Company and
(ii) Directors and Officers Errors and Omissions insurance in an amount of not less than $1
million. The Company shall maintain, until such time as the Board of Directors determines that
such insurance should be discontinued, “key-person” insurance on each of

19

 

Michael Simon and Marton Anka, each in an amount of not less than $1 million. The “key
person” policy shall name the Company as loss payee and neither policy shall be cancelable by the
Company without prior approval of the Board of Directors, such approval to include the approval of
each of the Preferred Directors then in office.

          5.2 Employee Agreements. The Company will cause (i) each person now or hereafter
employed by it or any subsidiary (or engaged by the Company or any subsidiary as a
consultant/independent contractor) with access to confidential information and/or trade secrets to
enter into a non-disclosure and proprietary rights assignment agreement and (ii) each Key Employee
to enter into a Employee Confidentiality, Invention Assignment and Non-Competition Agreement, in
substantially in the form attached hereto as Exhibit A. In addition, the Company shall not
amend, modify, terminate, waive or otherwise alter, in whole or in part, any of the
above-referenced agreements or any restricted stock agreement between the Company and any employee
without the consent of those members of the Board of Directors, such consent to include the consent
of each of the Preferred Directors then in office.

          5.3 Employee Vesting. Unless approved by the Board of Directors, such approval to
include the approval of each of the Preferred Directors then in office, of the Company, all future
employees and consultants of the Company who shall purchase, or receive options to purchase, shares
of the Company’s capital stock following the date hereof shall be required to execute stock
purchase or option agreements providing for (i) vesting of shares over a four-year period with the
first 25% of such shares vesting not sooner than following twelve (12) months of continued
employment or services to the Company by the grantee, and the remaining shares vesting in equal
quarterly installments over the following 36 months, (ii) a 180-day lockup period in connection
with the Company’s IPO and (iii) termination of the exercisability no later than ninety (90) days
after termination of the grantee’s service relationship with the Company. The Company agrees that
it shall be a condition to the grant of any further options to each employee of the Company that
such employee execute an amendment to such employee’s existing option agreements providing that the
options subject to such stock option agreements shall cease to be exercisable no later than ninety
(90) days after the termination of such employee’s service relationship with the company. The
Company shall retain a “right of first refusal” on employee transfers until the Company’s IPO and
the right to repurchase unvested shares at cost.

          5.4 Employee Compensation; Severance. The approval of the Compensation Committee of
the Board of Directors shall be required for: (a) annual cash compensation (including, without
limitation, base salary and bonuses) in excess of $125,000 for any employee of the Company, and/or
(b) any agreement to pay severance in excess of 30 days of an employee’s base salary;
provided, however, any salary and severance agreements entered into prior to the
date of this Agreement and fully disclosed to the Investors prior to the date of this Agreement
shall not be subject to this Section 5.4(b).

          5.5 Matters Requiring Investor Director Approval. So long as the holders of Preferred
Stock are entitled to elect a Preferred Director, the Company hereby covenants and agrees with each
of the Investors that it shall not, without the approval of the Board of Directors, such approval
to include the approval of each of the Preferred Directors then in office:

20

 

               (a) make, or permit any subsidiary to make, any loan or advance to any person, including,
without limitation, any employee or director of the Company or any subsidiary, except advances and
similar expenditures in the ordinary course of business or under the terms of a employee stock or
option plan approved by the Board of Directors, such approval to include the approval of each of
the then in office Preferred Directors;

               (b) make any investment, through the direct or indirect holding of securities or otherwise,
other than investments in prime commercial paper, money market funds, certificates of deposit in
any United States bank having a net worth in excess of $100,000,000 or obligations issued or
guaranteed by the United States of America, in each case having a maturity not in excess of two
years;

               (c) incur any aggregate indebtedness in excess of $100,000, other than trade credit incurred
in the ordinary course of business;

               (d) adopt any plan, agreements, arrangements for the awarding of bonuses, stock, options or
any equity incentive;

               (e) change the principal business of the Company, enter new lines of business, or exit the
current line of business;

               (f) sell, transfer, license, pledge or encumber material technology or intellectual property,
other than licenses granted in the ordinary course of business; or

               (g) enter into material agreements affecting the Company right to compete, including, without
limitation, the Company’s granting of exclusive licenses or exclusive dealing, the Company’s
agreement not to compete or the Company’s granting of most-favored customer or most-favored vendor
status;

               (h) enter into any commercial arrangements with a party related to the Company’s directors,
officers, employees or stockholders except on such terms that would be available on an arms’-length
basis from an unrelated third party;

               (i) open internal accounts or lines of credit for the personal benefit of any of the Company’s
directors, officers, employees or stockholders (other than in connection with any obligations owing
to such person in respect of his or her right to indemnity;

               (j) establish or change the Company’s car policy;

               (k) select or dismiss the Company’s auditor other than for gross malfeasance; or

               (l) make any change to the Company’s equity incentive plan (including increasing the number of
shares available for issuance thereunder) or alter the vesting schedule of any stock option grant
otherwise previously approved by the Board.

          5.6 Meetings of the Board of Directors. Unless otherwise determined by the vote of a
majority of the directors then in office, the Board shall meet at least four (4) times

21

 

annually, in accordance with a schedule approved by the Board, and, during each annual period,
at least one Board meeting will be held in the San Francisco Bay Area and at least one Board
meeting will be held in Budapest, Hungary.

          5.7 Termination of Covenants. The covenants set forth in this Section 5 shall
terminate and be of no further force or effect upon (a) consummation of a Qualified IPO and (b)
upon a Deemed Liquidation Event, as such term is defined in the Charter.

     6. Miscellaneous.

          6.1 Transfers, Successors and Assigns. The terms and conditions of this Agreement
shall inure to the benefit of and be binding upon the respective successors and assigns of the
parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other
than the parties hereto or their respective successors and assigns any rights, remedies,
obligations, or liabilities under or by reason of this Agreement, except as expressly provided in
this Agreement.

          6.2 Governing Law; Venue; Waiver of Jury Trial. This Agreement shall be governed by
and construed in accordance with the General Corporation Law of the State of Delaware as to matters
within the scope thereof, and as to all other matters shall be governed by and construed in
accordance with the internal laws of the Commonwealth of Massachusetts, without regard to its
principles of conflicts of laws. If the Agreement is translated into another language, the English
language version shall control if any dispute shall arise over the interpretation of the wording of
the Agreement. Each of the parties to this Agreement hereby agrees that the state and federal
courts of the Commonwealth of Massachusetts shall have exclusive jurisdiction to hear and determine
any claims or disputes between the parties hereto pertaining directly or indirectly to this
Agreement, and all documents, instruments and agreements executed pursuant hereto or thereto, or to
any matter arising here from (unless otherwise expressly provided for herein or therein). To the
extent permitted by law, each party hereby expressly submits and consents in advance to such
jurisdiction in any action or proceeding commenced by any of the other parties hereto in any of
such courts, and agrees that service of such summons and complaint or other process or papers may
be made by registered or certified mail addressed to such party at the address to which notices are
to be sent pursuant to this Agreement. Each of the parties waives any claim that Boston,
Massachusetts is an inconvenient forum or an improper forum based on lack of venue. The choice of
forum set forth in this Section shall not be deemed to preclude the enforcement of any judgment
obtained in such forum or the taking of any action to enforce the same in any other appropriate
jurisdiction. Each party hereto hereby waives, to the fullest extent permitted by applicable law,
any right it may have to a trial by jury in respect of any litigation directly or indirectly
arising out of, under or in connection with this Agreement. Each party hereto (i) certifies that
no representative, agent or attorney of the other party has represented, expressly or otherwise,
that the other party would not, in the event of litigation, seek to enforce the foregoing waiver
and (ii) acknowledges that it and the other parties hereto have been induced to enter into this
Agreement by, among other things, the mutual waivers and certifications in this Section.

          6.3 Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute

22

 

one and the same instrument. This Agreement may also be executed and delivered by facsimile
signature and in two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument.

          6.4 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement.

          6.5 Notices. All notices and other communications given or made pursuant to this
Agreement shall be in writing and shall be deemed effectively given: (a) upon personal delivery to
the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during
normal business hours of the recipient, and if not so confirmed, then on the next business day, (c)
five (5) days after having been sent by registered or certified mail, return receipt requested,
postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier,
specifying next day delivery, with written verification of receipt. All communications shall be
sent to the respective parties at their address as set forth on the signature page or Schedule A or
B (as applicable) hereto, or to such email address, facsimile number or address as subsequently
modified by written notice given in accordance with this Section 7.6. If notice is given
to the Company, a copy shall also be sent to Wilmer Cutler Pickering Hale and Dorr LLP, Attn: John
H. Chory, Esq., 1100 Winter Street, Suite 4650, Waltham, MA 02451. If notice is given to Intel
Capital Corporation, notice shall be sent to:

Intel Corporation

Attn: Intel Capital Portfolio Manager

2200 Mission College Blvd., M/S RN6-59

Santa Clara, CA 95052

Fax Number: (408) 653-6796

with a copy by e-mail to: portfolio.manager@intel.com

          6.6 Costs of Enforcement. If any Party to this Agreement seeks to enforce its rights
under this Agreement by legal proceedings, the non-prevailing Party shall pay all costs and
expenses incurred by the prevailing Party, including, without limitation, all reasonable attorneys’
fees.

          6.7 Amendments and Waivers. Any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a particular
instance and either retroactively or prospectively), only with the written consent of the Company
and the holders of 60% of the Registrable Securities then outstanding. Any amendment or waiver
effected in accordance with this paragraph shall be binding upon each holder of any Registrable
Securities then outstanding, each future holder of all such Registrable Securities, and the
Company. Notwithstanding the foregoing, this Agreement may not be amended or terminated and the
observance of any term hereunder may not be waived with respect to any Investor without the written
consent of such Investor, unless such amendment, termination or waiver applies to all Investors in
the same fashion (it being agreed that a waiver of the provisions of Section 4 with respect to a
particular transaction shall be deemed to apply to all Investors in the same fashion if such waiver
does so by its terms, notwithstanding the fact that certain Investors may nonetheless, by agreement
with the Company, purchase securities in such

23

 

transaction). The Company shall give prompt written notice of any amendment or termination
hereof or waiver hereunder to any party hereto that did not consent in writing to such amendment,
termination or waiver. Any amendment, termination or waiver effected in accordance with this
Section 6.7 shall be binding on all parties hereto, even if they do not execute such
consent. No waivers of or exceptions to any term, condition or provision of this Agreement, in any
one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of
any such term, condition or provision.

          6.8 Severability. The invalidity of unenforceability of any provision hereof shall in
no way affect the validity or enforceability of any other provision.

          6.9 Aggregation of Stock. All shares of Registrable Securities held or acquired by
Affiliates shall be aggregated together for the purpose of determining the availability of any
rights under this Agreement.

          6.10 Entire Agreement; Restatement of Prior Agreement. This Agreement (including the
Exhibits hereto, if any) constitutes the full and entire understanding and agreement between the
parties with respect to the subject matter hereof, and any other written or oral agreement relating
to the subject matter hereof existing between the parties are expressly canceled. Upon the
effectiveness of this Agreement, the Prior Agreement shall be amended and restated in its entirety
as set forth herein.

          6.11 Transfers of Rights. Each Investor hereto hereby agrees that it will not, and
may, not assign any of its rights and obligations hereunder, unless such rights and obligations are
assigned by such Investor to (a) any person or entity to which Registrable Securities are
transferred by such Investor, or (b) to any Affiliate of such Investor, and, in each case, such
transferee shall be deemed an “Investor” for purposes of this Agreement; provided that such
assignment of rights shall be contingent upon the transferee providing a written instrument to the
Company notifying the Company of such transfer and assignment and agreeing in writing to be bound
by the terms of this Agreement.

          6.12 Delays or Omissions. No delay or omission to exercise any right, power or remedy
accruing to any party under this Agreement, upon any breach or default of any other party under
this Agreement, shall impair any such right, power or remedy of such non-breaching or
non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an
acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any
waiver of any single breach or default be deemed a waiver of any other breach or default
theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or
character on the part of any party of any breach or default under this Agreement, or any waiver on
the part of any party of any provisions or conditions of this Agreement, must be in writing and
shall be effective only to the extent specifically set forth in such writing. All remedies, either
under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not
alternative.

[Remainder of Page Intentionally Left Blank]

24

 

     IN WITNESS WHEREOF, the parties have executed this Investor Rights Agreement as of the date
first above written.

	 	 	 	 	 
	 	LOGMEIN, INC.

 	 
	 	By:  	/s/
Michael Simon	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

[Investor Signature Pages Follow]

 

 

	 	 	 	 	 
	 	

INVESTORS:

POLARIS VENTURE PARTNERS IV, L.P.

By: Polaris Venture Management Co., IV, L.L.C.

       Its
General Partner

 	 
	 	By:  	/s/ William Bilodeau 	 
	 	 	William E. Bilodeau 	 
	 	 	Attorney-in-fact 	 
	 
	 	POLARIS VENTURE PARTNERS ENTREPRENEURS’ FUND IV, L.P.

By: Polaris Venture Management Co., IV, L.L.C.

       Its
General Partner

 	 
	 	By:  	/s/ William Bilodeau
 	 
	 	 	William E. Bilodeau 	 
	 	 	Attorney-in-fact 	 
	 
	 	PRISM VENTURE PARTNERS IV, L.P.

By: Prism Investment Partners IV, L.P.

       its
General Partner

By: Prism Venture Partners IV, L.L.C.

       its
General Partner

 	 
	 	By:  	/s/ [illegible]	 
	 	 	Managing Director 	 
	 	 	 	 
	 
	 	TECHNOLOGIEHOLDING CENTRAL AND EASTERN EUROPEAN FUNDS NV

 	 
	 	By:  	/s/ [illegible]	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

SIGNATURE PAGE TO SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 

 

	 	 	 	 	 
	 	INVESTORS (cont.):

TECHNOLOGIEHOLDING CENTRAL AND EASTERN

EUROPEANPARALLEL FUND BV

 	 
	 	By:  	/s/ [illegible]	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	INTEGRAL CAPITAL PARTNERS VI, L.P.

By: Integral Capital Management VI, LLC

       Its
General Partner

 	 
	 	By:  	/s/ [illegible]	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	 	 
	 	
 	 
	 	John B. Landry 	 
	 	 	 
	 
	 	 	 
	 	/s/ Michael Simon
 	 
	 	Michael Simon 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Marton Anka 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Sean Ellis 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Stephen Duzs 	 
	 	 	 
	 

SIGNATURE PAGE TO SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 

 

	 	 	 	 	 
	 	INVESTORS (cont.):

PRISM VENTURE FUNDS IV, L.P.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

SIGNATURE PAGE TO SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 

 

	 	 	 	 	 
	 	INVESTORS (cont.):

 	 
	 	
 	 
	 	George Holmes 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Robert Line 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Timothy Guest 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Adrian Friend 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Thomas Hardart 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Giles McNamee 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Andreas Kemi 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	William Ellis 	 
	 	 	 
	 
	 	SERIOUS CAPITAL CORP.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

SIGNATURE PAGE TO SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 

 

	 	 	 	 	 
	 	INVESTORS (cont.):

 	 
	 	
 	 
	 	Valentin Matafonov 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Jeff Hammill 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Ray Skoglund 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Mari Tangredi 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Kevin Bardos 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	Joe Eckert 	 
	 	 	 
	 
	 	 	 
	 	
 	 
	 	David Wieden 	 
	 	 	 
	 

[Remainder of Page Intentionally Left Blank]

SIGNATURE PAGE TO SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 

 

	 	 	 	 	 
	 	JENNYBEAR INVESTMENT LLC

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	INTEL CAPITAL CORPORATION

 	 
	 	By:  	/s/ Douglas M. Lusk	 
	 	 	Print Name: 	 	 
	 	 	Title:  	 	 
	 

THIS IS THE SIGNATURE PAGE FOR LOGMEIN, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
ENTERED INTO BY AND BETWEEN LOGMEIN, INC. AND INTEL CAPITAL CORPORATION AND PREFERRED STOCK
INVESTORS

SIGNATURE PAGE TO SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 

 

SCHEDULE A

Investors

Polaris Venture Partners IV, L.P.

1000 Winter Street

Suite 3350

Waltham, MA 02451

Polaris Venture Partners Entrepreneurs’ Fund IV, L.P.

1000 Winter Street

Suite 3350

Waltham, MA 02451

Prism Venture Funds IV, L.P.

100 Lowder Brook Drive

Suite 2500

Westwood, MA 02090

Integral Capital Partners VI, L.P.

3000 Sand Hill Road

Building 3, Suite 240

Menlo Park, CA 94025

Technologieholding Central and Eastern European Funds NV

c/o Amaco (Netherlands) B.V.

Amsteldijk 166

1079 LH Amsterdam

P.O. Box 74120, 1070 BC Amsterdam

The Netherlands

Technologieholding Central and Eastern Europeanparallel Funds BV

c/o Amaco (Netherlands) B.V.

Amsteldijk 166

1079 LH Amsterdam

P.O. Box 74120, 1070 BC Amsterdam

The Netherlands

John B. Landry

c/o Adesso Systems

1 Liberty Square

7th Floor

Boston, MA 02109

Michael Simon

C/O LogMeIn, Inc.

500 Unicorn Park Drive

Woburn, MA 01801

 

 

Marton Anka

C/O LogMeIn Kft

Erzsabet Krt 50 IV. Em.

Budapest H-1073, Hungary

Sean Ellis

67 South Bedford Street

Suite 400 West

Burlington, MA 01803

Stephen Duzs

Ho Utea 4

Budapest XII, Hungary

George Holmes

C/O LogMeIn, Inc.

500 Unicorn Park Drive

Woburn, MA 01801

Robert Line

C/O Keystone, Vármegye u. 3.-5.

H-1052 Budapest, Hungary

Timothy Guest

Sas u. 1. IV/3 A

Budapest H-1051 Hungary

Adrian Friend

Platz 6, Postfach 1000

Herisau 9102, Switzerland

Thomas Hardart

19931 Ebenezer Church Road

Bluemont, VA 20135 USA

Giles McNamee

C/O McNamee Lawrence & Co. LLC

425 Boylston Street, Third Floor

Boston, Massachusetts 02116

Andreas Kemi

Platz 6, Postfach 1000

Herisau 9102, Switzerland

William Ellis

1606 Anita Lane

Newport Beach, CA 92660 USA

A-2

 

Serious Capital Corp.

#901, 1010 Olympic Drive

Canmore, Alberta, Canada T1W 2S5

Valentin Matafonov

67 South Bedford Street

Suite 400 West

Burlington, MA 01803

Jeff Hammill

Falk Miksa u. 7. I/8.

Budapest H-1055 Hungary

Ray Skoglund

42 8th St., #5410

Charlestown, MA 02129

Joe Eckert

C/O LogMeIn, Inc.

500 Unicorn Park Drive

Woburn, MA 01801

Kevin Bardos

C/O LogMeIn Kft

Erzsabet Krt 50 IV. Em.

Budapest H-1073, Hungary

Mari Tangredi

14A Chestnut St

Boston, MA 02108

David Wieden

[Address]

Jennybear Investments LLC

c/o David ibnAle

2882 Sand Hill Road

Suite 280

Menlo Park, CA 94025

Intel Corporation

Attn: Intel Capital Portfolio Manager

2200 Mission College Blvd., M/S RN6-59

Santa Clara, CA 95052

Fax Number: (408) 653-6796

with a copy by e-mail to: portfolio.manager@intel.com

A-3

 

EXHIBIT A

FORM OF EMPLOYEE CONFIDENTIALITY, ASSIGNMENT OF

INVENTIONS AND NON-COMPETITION AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}]]